Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face

Background. For large basal cell carcinomas (BCCs) of the head and neck, definitive surgery often requires extensive resection and reconstruction that may result in prolonged recovery and limited cosmesis. Vismodegib, a small-molecule inhibitor of the hedgehog pathway, is approved for advanced and m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Oncol Med
Asıl Yazarlar: Block, Alec M., Alite, Fiori, Diaz, Aidnag Z., Borrowdale, Richard W., Clark, Joseph I., Choi, Mehee
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2015
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609426/
https://ncbi.nlm.nih.gov/pubmed/26504605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/827608
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller